http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070113382-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e559743173473475142b7bd8a978298 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
filingDate | 2006-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d703c755b159136720d7b571f52e69f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e110a99113def9755c3f2db368a31edb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd23ce766299169376a3a4a23c8ac628 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f7da329740a779bb0c0b4ada408c03d |
publicationDate | 2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20070113382-A |
titleOfInvention | Metformin sustained-release tablet |
abstract | The present invention relates to a sustained-release form of metformin, and more specifically, metformin, which is an active drug component of an insulin-independent diabetes treatment, and a matrix agent in which a hydrophilic polymer and a hydrophobic substance are mixed in a specific blending ratio, thereby selecting the hydrophilic polymer. It is possible to adjust the pore size of the gel layer formed by the water expansion thereof to control the release rate of the drug component primarily, and to block the pores of the gel layer by the selection of the hydrophobic material to secondary release rate of the drug component Since it is a commercially available metformin 500mg sustained release information, it shows excellent dissolution properties that can slowly release the drug components in the body at a constant rate even with the use of a small amount of matrix agent. Can maintain blood concentration, sense of size of the preparation Is possible by taking the said easily, commercially prepared by a simple method also relates to an improved sustained-release tablet Metformin shown a beneficial effect. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020004875-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130136718-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101043816-B1 |
priorityDate | 2006-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.